Tag: Counterfeit Medicines

The Globalisation of the Pharmaceutical Industry
Fight The Fakes
Falsified medicines
The value of import testing vs. surveillance testing
Défis n°5: Crime pharmaceutique, une épidémie silencieuse
WHA 68, Item 17.3, Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
Pour une approche intégrée contre les faux médicaments
Counterfeit medicines in legitimate supply chains SDCP & PSI Study
Counterfeit drug penetration into global legitimate medicine supply chains: A global assessment
IFPMA 2015 interview series 'The threat of counterfeit medicines'
IFPMA 2015 interview series 'Fake medicines: what are they? / Les faux médicaments: de quoi s’agit-ils?'
IFPMA Workshops on Counterfeit Medicines in Chinese Taipei
Fight the fakes campaign gains momentum as eleven new partners join global movement
La Fondation Chirac et l'IFPMA
IFPMA's 10 principles on counterfeit medicines
Watch out for false friends with Japanese subtitle / ニセ薬に気をつけろ! 日本語字幕
The IFPMA Ten Principles on Counterfeit Medicines
Watch out for false friends (Spanish subtitles)
Watch out for false friends (full version)
WHA 66 agenda item 17.1 on Substandard / spurious / falsely-labelled / falsified / counterfeit medical products
Introducing the study "Falsified medicines and the global public's health"
Fake medicines - imminent risks to global health
Fake medicines - Imminent risks to global health: remarks by Jamil Chade
Panel discussion: The threat of false friends fake medicines - Imminent risks to global health
UCL matrix insight: Falsified medicines and the global public health
Joint Industry Position on Medcrime Convention
Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines
Joint Industry Statement on Internet Sales and Access to Safe Medicines
WHA 65 agenda item 13.13 on Substandard / spurious / falsely-labelled / falsified / counterfeit medical products
Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 Dementia Developing World Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP IVS Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers